SBFMW (STOCKS)
Sunshine Biopharma Inc. warrant
$0.149600
+0.000000 (+0.00%)
Prev close: $0.149600
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals Major
- CEO
- Steve N. Slilaty, PhD
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- —
- Employees
- 52
- P/E (TTM)
- —
- P/B (TTM)
- —
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $36.31M |
| Benefits Costs and Expenses | $42.26M |
| Cost Of Revenue | $24.05M |
| Costs And Expenses | $42.26M |
| Gross Profit | $12.26M |
| Nonoperating Income/Loss | $273.29K |
| Operating Expenses | $18.48M |
| Research and Development | $604.31K |
| Other Operating Expenses | $17.88M |
| Operating Income/Loss | -$6.23M |
| Income/Loss From Continuing Operations After Tax | -$5.98M |
| Income/Loss From Continuing Operations Before Tax | -$5.95M |
| Income Tax Expense/Benefit | $21.61K |
| Income Tax Expense/Benefit, Deferred | $94.94K |
| Net Income/Loss | -$5.98M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$5.98M |
| Net Income/Loss Available To Common Stockholders, Basic | -$5.98M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.44 |
| Basic Average Shares | 4,157,086 |
| Assets | $30.08M |
| Current Assets | $26.85M |
| Inventory | $13.47M |
| Prepaid Expenses | $798.38K |
| Other Current Assets | $12.58M |
| Noncurrent Assets | $3.23M |
| Fixed Assets | $557.37K |
| Intangible Assets | $1.89M |
| Other Non-current Assets | $778.85K |
| Liabilities | $7.04M |
| Current Liabilities | $6.44M |
| Accounts Payable | $5.66M |
| Other Current Liabilities | $779.71K |
| Noncurrent Liabilities | $596.79K |
| Equity | $23.04M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $23.04M |
| Liabilities And Equity | $30.08M |
| Net Cash Flow From Operating Activities | -$5.33M |
| Net Cash Flow From Operating Activities, Continuing | -$5.33M |
| Net Cash Flow From Investing Activities | -$836.31K |
| Net Cash Flow From Investing Activities, Continuing | -$836.31K |
| Net Cash Flow From Financing Activities | $4.75M |
| Net Cash Flow From Financing Activities, Continuing | $4.75M |
| Net Cash Flow | -$1.42M |
| Net Cash Flow, Continuing | -$1.42M |
| Comprehensive Income/Loss | -$5.21M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$5.21M |
| Other Comprehensive Income/Loss | -$5.21M |